MUMBAI: Pharmaceutical companies offering buy-one-get-one-free schemes or 20% extra for the same price may have to pay goods and services tax (GST) on the extra quantities, raising prospect of the principle being applied to a broad spectrum of consumer products, said people with knowledge of the matter.
The tax heads of firms such as Novartis IndiaNSE 0.00 %, Sun PharmaNSE -0.14 %, CiplaNSE -0.53 %, LupinNSE 0.01 % have been summoned for meetings with tax officials, they said. The Direc ..
Read more at: https://bit.ly/2LGIEoQ
